(Q37777960)

23 August 2017

1 reference

title

The role of renal microvascular disease and interstitial inflammation in salt-sensitive hypertension (English)

1 reference

23 August 2017

main subject

arterial hypertension

0 references

inflammation

0 references

microvessel

0 references

author name string

Bernardo Rodriguez-Iturbe

series ordinal

1

1 reference

23 August 2017

Richard J. Johnson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20686485

17 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20686485

17 June 2024

publication date

5 August 2010

1 reference

full work available at URL

23 August 2017

https://www.nature.com/articles/hr2010148.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20686485

http://www.jstage.jst.go.jp/article/hypres/33/10/33_975/_article

17 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20686485

17 June 2024

published in

Hypertension Research

1 reference

23 August 2017

volume

33

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

975-980

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2010.148

23 August 2017

exact match

0 references

cites work

Essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

A comprehensive review on salt and health and current experience of worldwide salt reduction programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Projected effect of dietary salt reductions on future cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Effects of interstrain renal transplantation on NaCl-induced hypertension in Dahl rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Sodium and volume sensitivity of blood pressure. Age and pressure change over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Pathophysiological mechanisms of salt-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Blood pressure control--special role of the kidneys and body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Structure and function of the arteries in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Subtle acquired renal injury as a mechanism of salt-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Renal injury and salt-sensitive hypertension after exposure to catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Subclinical renal injury induced by transient cyclosporine exposure is associated with salt-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Chronic potassium depletion induces renal injury, salt sensitivity, and hypertension in young rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Hypertension in Page (cellophane-wrapped) kidney is due to interstitial nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

The gamma-subunit of ENaC is more important for channel surface expression than the beta-subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Associations of glomerular number and birth weight with clinicopathological features of African Americans and whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Regulation of intrarenal angiotensin II in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Renal medullary oxidative stress, pressure-natriuresis, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Increased renal medullary oxidative stress produces hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

How is plasma calcium held constant? Milieu interieur of calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

TGF-beta impairs renal autoregulation via generation of ROS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Pathophysiology of hypertensive renal damage: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Antihypertensive effect of interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Heat shock proteins and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Stress proteins and immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

Potential societal savings from reduced sodium consumption in the U.S. adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Hypertension explained by Starling's theory of circulatory homoeostasis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Genetic Influence of Renal Homografts on the Blood Pressure of Rats from Different Strains

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

The role of the kidney in the development of hypertension: a transplantation study in the Prague hypertensive rat

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Remission of essential hypertension after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

The Anatomy of Bright's Disease: The "Arterio-Capillary Fibrosis" of Sir Wm. Gull and Dr. Sutton

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

The Etiology of Bright's Disease and the Prealbuminuric Stage

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

The renal origin of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Renal factors in the production of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Hypertensive vascular disease; description and natural history

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Clinicopathologic correlations of renal biopsies from essential hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Regulation of papillary plasma flow by angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Immune system modulation and its effect on the blood pressure of the spontaneously hypertensive male and female rat

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Angiotensin II hypertension is attenuated in interleukin-6 knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Autoantibodies in Untreated and Treated Essential Hypertension. I

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

AIDS, lupus, rheumatoid arthritis--hypertension?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Failure of the heat-shock protein 70 locus to cosegregate with blood pressure in spontaneously hypertensive rat x Wistar-Kyoto rat cross

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

The roles of angiotensin II and prostaglandins in the regulation of the glomerular filtration of albumin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Vimentin and heat shock protein expression are induced in the kidney by angiotensin and by nitric oxide inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Circulating heat shock protein and heat shock protein antibody levels in established hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Experimental induction of salt-sensitive hypertension is associated with lymphocyte proliferative response to HSP70

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.148

7 January 2021

Identifiers

DOI

10.1038/HR.2010.148

1 reference

23 August 2017

1 reference